Abstract
A 61-year-old-female with a 4-year history of disseminated granuloma annulare was successfully treated with the antitumor necrosis factor (TNF)-alpha antibody, adalimumab. The patient had failed high potency topical glucocorticoids, hydroxychloroquine, and narrow-band ultraviolet light (UV)-B phototherapy. Anti-TNF-alpha therapy may be a therapeutic option in patients with disseminated granuloma annulare poorly controlled with conventional medications.
Original language | English |
---|---|
Pages (from-to) | 169-171 |
Number of pages | 3 |
Journal | Journal of Drugs in Dermatology |
Volume | 8 |
Issue number | 2 |
State | Published - Feb 2009 |
Externally published | Yes |